The Bipartisan Commission on Biodefense is a privately funded entity established in 2014 to provide for a comprehensive assessment of the state of U.S. biodefense efforts and to issue recommendations that will foster change.
From 2014-2015, the Commission convened four public meetings in Washington, DC on biological threat awareness, prevention and protection, surveillance and detection, and response and recovery. Current and former Members of Congress, former Administration officials, state and local representatives, thought leaders, and other experts provided their perspectives on current biodefense efforts, including strengths, weaknesses, and opportunities. While much good work has been achieved toward biodefense, these meetings have revealed systemic challenges in the enterprise designed to protect Americans from biological events.
The Commission continues to advocate for uptake of these recommendations at the highest levels of American government, through additional meetings, reports, and other activities, and is the only such body of bipartisan, former high-level policymakers to do so.
All content for Bipartisan Commission on Biodefense is the property of Bipartisan Commission on Biodefense and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Bipartisan Commission on Biodefense is a privately funded entity established in 2014 to provide for a comprehensive assessment of the state of U.S. biodefense efforts and to issue recommendations that will foster change.
From 2014-2015, the Commission convened four public meetings in Washington, DC on biological threat awareness, prevention and protection, surveillance and detection, and response and recovery. Current and former Members of Congress, former Administration officials, state and local representatives, thought leaders, and other experts provided their perspectives on current biodefense efforts, including strengths, weaknesses, and opportunities. While much good work has been achieved toward biodefense, these meetings have revealed systemic challenges in the enterprise designed to protect Americans from biological events.
The Commission continues to advocate for uptake of these recommendations at the highest levels of American government, through additional meetings, reports, and other activities, and is the only such body of bipartisan, former high-level policymakers to do so.
July 22, 2025 - In this meeting, the Bipartisan Commission on Biodefense explores: (1) core requirements for effective national biodefense; (2) Administration biodefense priorities; (3) impacts of department and agency realignment; and (4) strategies for addressing future biological threats.
Speakers include:
Michael Place, MD (Major General, US Army – Retired) – Former Chief of Staff, Office of the Surgeon General, US Army Command, US Army
Erica Pan, MD, MPH – Director and State Public Health Officer, California Department of Public Health
Alex Hamberg, VMD, PhD – State Veterinarian, Pennsylvania Department of Agriculture
Clint Osborn – Director, District of Columbia Homeland Security and Emergency Management Agency
Lori Tremmel Freeman, MBA – Chief Executive Officer, National Association of County and City Health Officials
Tina Tan, MD, FIDSA, FPIDS, FAAP – President, Infectious Disease Society of America
Ali S. Khan, MD, MPH – Dean, College of Public Health, University of Nebraska Medical Center
Richard J. Hatchett, MD – Chief Executive Officer, Coalition for Epidemic Preparedness Innovations
Matthew Hepburn, MD – Executive Vice President, Research and Development, Panther Life Sciences
Leonard J. Marcus, PhD – Co-Director, National Preparedness Leadership Initiative, Harvard University
Taylor Sexton, MPH – Executive Director, Medical Countermeasures Coalition
David Stiefel, MA – Director, Global Biological Policy and Programs, Nuclear Threat Initiative
Joe Buccina, MA, MS– Policy and Research Director, National Security Commission on Emerging Biotechnology
Patricia R. Bright, DVM – Former Senior Science Advisor, One Health/Global Health Security, US Geological Survey
Learn more here: https://biodefensecommission.org/events/biodefense-in-crisis-danger-and-opportunity/
Bipartisan Commission on Biodefense
The Bipartisan Commission on Biodefense is a privately funded entity established in 2014 to provide for a comprehensive assessment of the state of U.S. biodefense efforts and to issue recommendations that will foster change.
From 2014-2015, the Commission convened four public meetings in Washington, DC on biological threat awareness, prevention and protection, surveillance and detection, and response and recovery. Current and former Members of Congress, former Administration officials, state and local representatives, thought leaders, and other experts provided their perspectives on current biodefense efforts, including strengths, weaknesses, and opportunities. While much good work has been achieved toward biodefense, these meetings have revealed systemic challenges in the enterprise designed to protect Americans from biological events.
The Commission continues to advocate for uptake of these recommendations at the highest levels of American government, through additional meetings, reports, and other activities, and is the only such body of bipartisan, former high-level policymakers to do so.
